Case Report: MECP2 and SH3KBP1 variants associated with autism spectrum disorder and immune dysregulation
Clinical Scorecard: Clinical Report: Variants in MECP2 and SH3KBP1 Linked to Autism Spectrum Disorder and Immune System Abnormalities
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | Genetic variants in MECP2 and SH3KBP1 associated with neurodevelopmental impairment and immune dysregulation. |
| Target Population | |
| Care Setting | |
Key Highlights
- Two male patients with ASD, neurodevelopmental delay, and immune dysregulation.
- Genetic analysis revealed MECP2 duplication and SH3KBP1 deletion.
- Patients exhibited recurrent infections and congenital cardiac anomalies.
- Emphasizes the need for genetic testing and immunological evaluation in ASD.
- Highlights phenotypic variability in MECP2 duplication syndrome and SH3KBP1 variants.
Guideline-Based Recommendations
Diagnosis
- Consider comprehensive genetic testing in patients with complex neurodevelopmental presentations.
- Genetic counseling for families of affected patients.
Management
- Evaluate for immune dysregulation in ASD patients presenting with recurrent infections or systemic abnormalities.
- Consider specific treatments for identified immune dysregulation.
Monitoring & Follow-up
- Monitor for recurrent infections and immunological abnormalities in ASD patients.
Risks
- Increased risk of recurrent infections and immune-related complications.
Patient & Prescribing Data
Pediatric patients diagnosed with ASD and associated immune dysregulation.
Management may require a multidisciplinary approach including immunological assessment.
Clinical Best Practices
- Incorporate immunological evaluation in ASD patients with atypical clinical features.
- Recognize the potential for overlapping neurodevelopmental and immunological disorders.
- Emphasize interdisciplinary collaboration in managing these patients.
Related Resources & Content
